- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03163069
The Effect of Whitening Toothpaste on Tooth Color Associated With Bleaching Process
October 7, 2017 updated by: Hao Yu, Fujian Medical University
Does Use of a Whitening Dentifrice Improve the Efficiency of In-office Tooth Bleaching Procedures? A Double-blind Randomized Controlled Clinical Trial.
This double-blind randomized controlled clinical trial aimed to investigate the effect of whitening dentifrices on the clinical efficiency of in-office tooth bleaching procedures.
Study Overview
Status
Completed
Conditions
Detailed Description
Sixty-three eligible participants (29 males and 34 females, mean age 26.1 years) with at least one maxillary tooth demonstrating shade A3 or darker will be recruited and randomly allocated into 3 groups (n = 21), according to the different dentifrices used in this clinical trial: Crest Total (regular dentifrice) for group C, Crest 3D Whitening (conventional whitening dentifrice) for group CW, and Close Up White Now (whitening dentifrice containing blue covarine) for group CU.
All participants will receive in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%) for the maxillary anterior teeth (2 sessions, with a 1-week interval).
The participants will be instructed to use only the provided dentifrices and toothbrushes to brush their teeth twice daily over a 4-week period.
Colour parameters (CIE L*, a*, b*) will be measured with a spectrophotometer (Vita Easyshade Advance 4.0) at baseline (T1), after the first bleaching session (T2), after the second bleaching session (T3), 1 week after the completion of in-office bleaching (T4), and 3 weeks after the completion of in-office bleaching (T5).
The colour differences (ΔE) and whiteness index (W) will also be calculated.
The data will be statistically analysed through repeated ANOVA and Tukey's test (α = 0.05).
Study Type
Interventional
Enrollment (Actual)
63
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fujian
-
Fuzhou, Fujian, China, 350004
- Fujian Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 58 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients between 18 and 60 years of age, with fully erupted upper and lower incisors and canines without dental or periodontal disease or restorations, and with at least one maxillary tooth presenting color score A3 or darker, as measured with the Vita Classical guide (Vita Zahnfabrik, Bad Sa ̈ ckingen, Germany) ordered by brightness
Exclusion Criteria:
- patients with systemic diseases or oral mucosal disorders, previous bleaching treatment, patients undergoing orthodontic treatment, pregnant women, people with known allergy to the product ingredients, smokers, and alcohol abusers.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Conventional Whitening dentifrice
in-office bleaching with the conventional whitening dentifrice
|
Participants will receive in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%) for the maxillary anterior teeth (2 sessions, with a 1-week interval).
During the tooth bleaching procedure and 3 weeks after the procedure, the participants will be instructed to brush their teeth twice with the conventional whitening dentifrice.
|
Experimental: Whitening dentifrice containing blue covarine
in-office bleaching with the whitening dentifrice containing blue covarine
|
Participants will receive in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%) for the maxillary anterior teeth (2 sessions, with a 1-week interval).
During the tooth bleaching procedure and 3 weeks after the procedure, the participants will be instructed to brush their teeth twice with the whitening dentifrice containing blue covarine.
|
Experimental: Regular dentifrice
in-office bleaching with the regular dentifrice
|
Participants will receive in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%) for the maxillary anterior teeth (2 sessions, with a 1-week interval).
During the tooth bleaching procedure and 3 weeks after the procedure, the participants will be instructed to brush their teeth twice with the regular dentifrice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in tooth colour
Time Frame: 4 weeks
|
Colour parameters (CIE L*, a*, b*) will be measured with a spectrophotometer (Vita Easyshade Advance 4.0).
The color alteration after each session will be given by the differences between the values obtained at the sessions and the baseline (∆E).
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in tooth whiteness
Time Frame: 4 weeks
|
The whiteness index will be registered at the sessions and the baseline.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hao Yu, Fujian Medical University, China
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 18, 2017
Primary Completion (Actual)
July 2, 2017
Study Completion (Actual)
August 24, 2017
Study Registration Dates
First Submitted
May 16, 2017
First Submitted That Met QC Criteria
May 19, 2017
First Posted (Actual)
May 22, 2017
Study Record Updates
Last Update Posted (Actual)
October 10, 2017
Last Update Submitted That Met QC Criteria
October 7, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20170318
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tooth Discoloration
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityUnknownDiscoloration, Tooth
-
Cairo UniversityNot yet recruitingDiscoloration, Tooth | Abrasion
-
Technische Universität DresdenCompletedDiscoloration of TeethGermany
-
Aristotle University Of ThessalonikiCompleted
-
Cairo UniversityChildren's Cancer Hospital Egypt 57357RecruitingDiscoloration, Tooth | Secondary Caries | Fracture ToothEgypt
-
Cairo UniversityRecruitingDiscoloration, Tooth | Chip Tooth | Non Vital Teeth | Trauma DentalEgypt
Clinical Trials on in-office bleaching with the conventional whitening dentifrice
-
Universidade Estadual de Ponta GrossaCompletedTooth DiscolorationBrazil
-
Damascus UniversityCompletedDental Plaque | Dental Care | Dental ProphylaxisSyrian Arab Republic
-
Universitat Pompeu FabraHospital de la EsperanzaCompletedCognition Disorders | Cognitive Deficits
-
Universidad Europea de MadridCompletedLower Limb Lymphedema
-
Mansoura UniversityActive, not recruiting
-
Cluster de Bioeconomia de Baja California, A.CBionag SAPI de CV; General Hospital TijuanaCompletedCoronavirus Disease 2019 (COVID-19)Mexico
-
AeskuLab Pathology PragueInstitute of Biostatistics and analyses, Ltd.CompletedAlgorithm for Cervix Carcinoma ScreeningCzechia
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; McMaster UniversityCompleted
-
Centre hospitalier de l'Université de Montréal...WithdrawnRuptured Aneurysm of Intracranial ArteryCanada